Search results
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 11 hours agoWithout approval from the FDA, though, Novavax recorded negative product...to the Centers for...
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and...
Morningstar· 2 days agoFood and Drug Administration (FDA) has cleared the QIAstat-Dx Respiratory...infections and covers 21 viral and bacterial ...
House OK’s rice tariffication law amendments on 2nd reading - BusinessWorld Online
BusinessWorld· 4 hours agoTHE HOUSE of Representatives on Tuesday approved on second reading a bill that seeks to allow the...
FDA issues warning to Cue Health over COVID-19 test By Investing.com
Investing.com· 20 hours agoCue Health Inc. (NASDAQ:HLTH), a healthcare technology company, has received a warning letter from...
FDA issues recall for diabetes app after over 200 reported injuries
Popular Science via Yahoo News· 5 days agoOnce downloaded, t:connect works alongside Tandem’s t:slim X2... investigation determined a software...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 2 weeks agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 4 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shotand develop combination...
The End of an Era? FDA Finalizes LDT Rule But Grandfathers Many Existing LDTs | JD Supra
JD Supra· 1 week agoOn May 6, 2024, the Food and Drug Administration (FDA) published its final rule for laboratory developed tests (LDTs). The final rule cemented the agency ...
FDA Issues Final Rule Regulating Many Laboratory-Developed Tests as Medical Devices | JD Supra
JD Supra· 2 weeks agoThe final rule amends FDA’s regulations to make explicit that IVDs are devices under the Federal Food, Drug, and Cosmetic Act (FDCA), including when the ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
FOX 23 News Albany· 5 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new ...